RALEIGH, N.C., June 16, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), announced today that on June 15, 2009, it entered into and closed a securities purchase agreement (SPA) with certain accredited investors providing for the sale to those investors of 3,433,884 units. Gross proceeds to DARA from this sale were $1,397,000, and net proceeds after placement agent fees were $1,298,180.
